USC Schaeffer Center Webinar on Precision Medicine: Measuring Real-World Effectiveness & Value

Thursday, June 17, 2021 - 08:30

Precision therapies are often approved based on small trials, in specialized settings, and using biomarkers as endpoints.  Thus, despite their potential high cost, the evidence of value is lacking which makes real-world evidence crucial. Join Schaeffer Center Director of Research Darius Lakdawalla in discussion with MIT NEWDIGS Director of Research Kay Larholt and Merck Center for Observational and Real-World Evidence Executive Director Megan O’Brien for a discussion about how we should measure and leverage real-world data to assess the value of precision medicines.